RIGHT Frequently Asked Questions Date of issue: Updated 20 July 2018

Transcription

1 NIHR Research and Innovation for Global Health Transformation (RIGHT) Call 1 Frequently Asked Questions Table of Contents RIGHT scope and aims What is the scope and remit of the NIHR RIGHT Call 1? Is research into infection-related cancer not listed in the remit eligible? Are more common stigmatising skin diseases in remit? Does leprosy, a known stigmatized skin disease still prevalent in the poorest communities in LMICs, qualify for this call? Will you be concentrating on Neglected Tropical Diseases (NTDs) or more general stigmatising/disabling skin conditions? Is prospective collection and analysis of patient samples OK? Can you clarify what is expected in terms of the project delivering patient benefit? Will RIGHT fund basic science or experimental medicine? Does RIGHT fund animal research? Will RIGHT fund systematic reviews? Are studies of diagnostic tests supported? I would like to include the development of an information resource for patients and/or LMIC communities, (e.g. leaflet, video, website, etc.) as part of my research proposal. Is this supported? Will you cover costs for training in the LMIC? Will RIGHT fund PhD research? In order to capacity build LMIC staff, what educational opportunities are possible? Can they earn graduate degrees from other non-lmic countries as long as they remain the majority of time based in the LMIC during the project? How can we develop a robust partnership framework within such a short timeframe? The most we can do now is secure willingness to collaborate from our LMICs partners. Is research to do with social care eligible for this call? I would like to apply for funding to carry out a feasibility study and am not sure whether to apply to RIGHT or one of the other NIHR programmes. 1

2 Will any special criteria apply to requests to fund feasibility studies? How much 'discovery' work is permitted e.g. identification of new diagnostic/prognostic biomarkers? Is implementation research within the scope if there is a robust evaluation, before and after the implementation of the intervention, on the health benefit? The call guidance states that applications solely comprising a single Randomised Controlled Trial (RCT) will not be funded, please can you clarify? Would the call consider providing part funding for studies? Eligibility Do applications to the RIGHT call have to fulfil Official Development Assistance (ODA) eligibility? Can research teams that were unsuccessful in other NIHR Global Health Calls re-apply? What organisations are eligible to apply for funding from RIGHT? What types of organisations can be party to an application to RIGHT? Can a HEI submit multiple applications to RIGHT Call 1? What is the RIGHT policy on partnering with co-applicants or organisations within LMICs? Can an organisation outside of the UK submit an application? Can organisations in LMICs be lead applicants? Can more than one organisation collaborate in a joint application to RIGHT? Are there any issues in collaborating with international organisations such as World Health Organization? Can an individual researcher be involved in other applications as collaborators or co-applicants if they are the leading applicant on another application? Can current NIHR GHR award holders apply to the RIGHT Call 1? Will the NIHR act as research sponsor for the projects that are funded via this call? Your proposal Are there any guidelines on how the funding should be split between the lead UK institution and any LMIC organisation? Can the projects be based in an LMIC? Will LMIC partners receive direct funding from NIHR or via the lead UK institution? Can funding be disbursed to LMIC institutions? Are there any policy restrictions on the location for the research? i.e.: are there countries that would not be allowed to receive funds/be supported. How many LMIC partners are expected? I am planning on conducting a study / delivering an intervention in an LMIC healthcare setting. Can you explain how to categorise the costs? 2

3 Could you clarify if it is permitted to include more than one LMIC in the proposal and if this is preferred or if a single country applicant is equally acceptable? Who should be included as co-applicants from LMIC researchers and delivery partners? Can we include both academic partners and delivery partners in the LMICs? What is considered value for money? Will projects costed under 3m/over 5m be funded? How many projects are you expecting to fund? Can we cost for research posts in the LMIC where there is currently none? What about the cost of UK-based project managers / supervisors which will be involved in project management and project monitoring and evaluation? Are you saying these costs will be ineligible? My study involves delivery of an intervention in the UK NHS, how should this be categorised? Do I need to account for inflation when costing the application? Is it possible for directly-incurred staff to also be co-investigators? Or is it only directly-allocated staff who can be co-investigators? Could you confirm whether the 5,000 equipment cost limit this is for all smaller pieces of equipment purchased, or that no single item can cost more than 5K, but multiple items can be purchased which could total over 5,000? Can more than 5,000 be used for updating existing items of equipment, rather than purchasing new items? What value should be added to the Stage 1 Financial Summary Form for a UK based Higher Education Institution, 100% FEC or the amount being requested from NIHR, i.e. 80% FEC? Can larger items of equipment for more than 5,000 be purchased by including some costs within estates charges? What is considered to be appropriate community and public involvement in a RIGHT application? When is the deadline for submitting questions on the call remit or process? 3

4 RIGHT scope and aims What is the scope and remit of the NIHR RIGHT Call 1? RIGHT is a response mode/researcher-led call for applied health research in low and middle income countries (LMICs). It is intended to provide an opportunity for research in areas of unmet need in LMICs, with the primary benefit of the research for the poorest individuals in LMICs. As such, the research needs to have a demonstrable impact on the health and wealth of LMICs. The potential benefit to LMICs is a major selection criteria, alongside rigorous research designs and methodologies. The NIHR RIGHT Call 1 will support: applied health research projects/programmes that are of primary and direct benefit to people and patients in LMICs, which address the challenges faced by LMICs; interdisciplinary applied research teams with demonstrable expertise and a track record of ensuring clinical research is transferred into benefits for patients this can include teams in LMICs as well as teams and researchers who may want to build new research partnerships with colleagues in LMICs or apply their research expertise to global health challenges in these areas; proposals that incorporate research questions around gender, social barriers to health, economic impact and equity, that demonstrate strong partnerships with institutions in LMICs; applications which include appropriate researchers from disease endemic regions and demonstrate equitable research partnerships; applications which demonstrate plans for equitable partnership building and engagement between UK research organisations and researchers and other partners in LMICs; applications which include relevant engagement with policy makers, patients and the public, civil society organisations and charities. Is research into infection-related cancer not listed in the remit eligible? No, the aim of RIGHT Call 1 is to support health research in areas of un-met needs or neglected investment. The prioritisation to the four listed infection-related cancers is in line with the RIGHT Call s strategy to focus on specific cancers where a targeted investment has the potential for a transformative impact. NIHR endeavour to complement other ODA funded research (such as the recently closed GCRF Call on Cancer and Global Health) which have a wider remit. Are more common stigmatising skin diseases in remit? The focus of the call is on reducing the public health burden of severe stigmatising skin diseases. The severity and the impact on public health burden of the condition is key. Where eczema/common skin diseases are to be studied alongside more severe conditions, there needs to be clear and steadfast justification as to why this is required. Does leprosy, a known stigmatized skin disease still prevalent in the poorest communities in LMICs, qualify for this call? Yes, leprosy is within scope of the call. The severity and the impact on public health burden of the condition is key. 4

5 Will you be concentrating on Neglected Tropical Diseases (NTDs) or more general stigmatising/disabling skin conditions? Stigmatising/disabling skin conditions is the focus for this call and it is not limited to only those skin conditions contained on the WHO list of 18 Neglected Tropical Diseases (NTDs). Is prospective collection and analysis of patient samples OK? Yes, as a wider programme of work, however as per the call guidance the call will not support the establishment of new Biobanks. Can you clarify what is expected in terms of the project delivering patient benefit? Applications to RIGHT must demonstrate a trajectory to patient benefit in LMICs. Benefit to the poorest individuals living in LMICs is a major selection criteria for RIGHT applications. In all applications to RIGHT, it is expected that the research will seek to demonstrate realisable and quantifiable benefits to LMICs and that the route to that benefit is clearly set out in the proposal. Will RIGHT fund basic science or experimental medicine? RIGHT will not fund projects that are solely basic science. It may be possible to make a case for a project, which has an element of basic science, but the justification would need to be around the likely benefit to patients health in LMICs. Does RIGHT fund animal research? The NIHR does not itself fund basic research or work involving animals and/or animal tissue. The NIHR recognises that the carefully regulated use of animals in research is important in understanding disease and in developing safe and effective ways of preventing or treating illness. NIHR also recognises the need for robust application of the 3Rs that animals are replaced with non-animal alternatives wherever possible, that the number of animals used is reduced to the minimum needed to achieve the results sought, and that, for those animals which must be used, procedures are refined as much as possible to minimise their suffering. NIHR therefore supports the Government s policies on research using animals set out in Working to reduce the use of animals in scientific research. NIHR works in close partnership with the Medical Research Council which funds animal research in carefully defined circumstances. NIHR funding is focused on clinical and applied health and care research. Will RIGHT fund systematic reviews? Systematic reviews may be funded as an element in a research design, when appropriate, but RIGHT is not a primary source of funding for systematic reviews. Systematic reviews fall within Tier 3 and are expected to cost less than 150,000. Please see the Guidance on funding limits for more information. We will consider funding reviews: that are likely to provide a guide to action (what the service providers should be doing or what they should stop doing) as opposed to identifying knowledge gaps where a practitioner or researcher has identified a particular area where it is important to have clarity about the best evidence available. PLEASE NOTE: Applicants undertaking systematic reviews should note the commitment of NIHR to registration in the PROSPERO database. PROSPERO was developed by the NIHR s Centre for Reviews and Dissemination (CRD), and is the first international online facility to prospectively register systematic reviews for research about health and social care. Access is free of charge and open to 5

6 the public. PROSPERO registration is a condition of NIHR funding for systematic reviews. It is accepted that not all systematic reviews commissioned by the NIHR programmes will fall into the scope of the CRD register. The immediate focus is on reviews of the effects of interventions and strategies to prevent, diagnose, treat, and monitor health conditions for which there is a health related outcome. A review should also only be registered once it is in receipt of confirmed funding, and not before. The timing of registration should be at the point when the protocol is complete/stable but before screening studies for eligibility has begun. It is at this point where intentional, or inadvertent, bias could come into play i.e. manipulating the inclusion criteria to capture those studies that show a particular desired result. Researchers are required, once registered on PROSPERO, to keep their protocol up to date. This includes mirroring any major protocol amendments, updating status when completed (or abandoned) and adding publication details when published. Registration should take place on the PROSPERO website. Are studies of diagnostic tests supported? Stand-alone studies of diagnostic accuracy may be within the scope of RIGHT. There are a number of types of diagnostic study which will be considered by NIHR RIGHT. (a) Diagnostic utility studies examine the value of a diagnostic test in improving patient outcomes in the LMIC setting, and are often designed as trials and powered on relevant clinical endpoints. Economic outcomes may also be important. (b) The development of a new test or instrument that will be used in the LMIC setting and/or the broad assessment of its reliability and validity in that setting. These might range from questionnaires that identify mental states to molecular assays. Test development and/or testing for psychometric properties or analytic validity, as it is called in the ACCE framework, will only be supported where the test technology is required in the LMIC, the technology and/or instrument already relatively welldeveloped and there is a clear pathway to LMIC community and patient benefit. I would like to include the development of an information resource for patients and/or LMIC communities, (e.g. leaflet, video, website, etc.) as part of my research proposal. Is this supported? NIHR views the provision of high quality, accessible information to LMIC communities and patients as conferring benefit, as such information can empower the community and patients to better manage their conditions and make informed choices about their treatment options and/or their participation in the research. However, the applicant must demonstrate that the relevant information is not already available to the community via another medium, and must make sure that their information resource format is appropriate to the LMIC context. Therefore, a RIGHT application that proposes an information resource output will need to include details of any existing information available, and a justification of the need for a new resource including details on the target audience and impact of the format of the proposed resource. 6

7 Will you cover costs for training in the LMIC? Yes, the RIGHT Call encourages inclusion of training for those based in LMICs to support capacity building. Will RIGHT fund PhD research? The NIHR does not fund PhD studentships in the UK through its research programmes. It is possible, however, for a researcher employed to work on an NIHR funded research project to register for a PhD based on the funded project, although RIGHT would not reimburse fees. More details about NIHR s main training opportunities can be found on the training pages. However, the NIHR will fund the full PhD costs in LMIC. In order to capacity build LMIC staff, what educational opportunities are possible? Can they earn graduate degrees from other non-lmic countries as long as they remain the majority of time based in the LMIC during the project? Yes - but please check with office on fees and other costs before application How can we develop a robust partnership framework within such a short timeframe? The most we can do now is secure willingness to collaborate from our LMICs partners. We recognise that Stage 1 has a swift turnaround time and understand that development of comprehensive partnerships is challenging. We will ensure that the panel is sympathetic to this element and focuses their attention on what has been practical and the potential of the planned partnerships, which can be further developed in Stage 2. To support partnership building, applicants that are successful at Stage 1 and invited to submit a Stage 2 application will be eligible to apply for funding of up to 10,000 to support proposal and partnership development, and the preparation of the full proposal to be submitted for Stage 2 Is research to do with social care eligible for this call? Applied health and social care research is eligible for RIGHT funding. Please note that funding for the NIHR RIGHT Call 1 comes from the government s commitment to Official Development Assistance (ODA). The applicant therefore needs to show a demonstrable benefit to the poorest individuals living in LMICs. I would like to apply for funding to carry out a feasibility study and am not sure whether to apply to RIGHT or one of the other NIHR programmes. Context appropriate feasibility studies or pilot studies carried out in the LMIC setting are eligible for funding via RIGHT, and should be described as part of your overall research application. NIHR RIGHT funding is targeted at delivery of research in LMICs and would not fund feasibility studies that are to be carried out in the UK or any other non-lmic partner country. Will any special criteria apply to requests to fund feasibility studies? RIGHT is only able to consider requests for funding feasibility studies that are to be delivered in the LMIC setting and that are part of a larger research plan. Carrying out initial work is frequently essential for a sound research design and lack of preliminary feasibility work can result in a waste of resources, especially when a complex intervention is proposed or the intervention is being delivered in an unfamiliar setting such as an LMIC. Therefore RIGHT applications can include feasibility studies, 7

8 providing these studies are conducted in the LMIC setting. Such feasibility studies should be described as a discrete part of the overall research plan. They must be clearly identifiable in the research plan, with defined outputs and clearly justified costings. Note RIGHT will not fund feasibility studies that are to be carried out in a non LMIC setting. How much 'discovery' work is permitted e.g. identification of new diagnostic/prognostic biomarkers? Early-stage work such as this is permitted as part of a wider programme of work but applications must identify a clear route through to implementation of findings. Please contact the office for a specific discussion if that would be helpful. Is implementation research within the scope if there is a robust evaluation, before and after the implementation of the intervention, on the health benefit? Yes, however as stated in the Guidance for Applicants, applications consisting solely of evaluations are not in remit. The evaluation should be part of a wider programme of work. The call guidance states that applications solely comprising a single Randomised Controlled Trial (RCT) will not be funded, please can you clarify? To clarify: where RCT is proposed we expect this to be part of a wider package of work (i.e.: not the sole activity). We do not require multiple RCTs in a proposal. A proposal consisting of varied work packages including one comprising a 'feasibility trial' would be in scope / eligible (providing that the feasibility trial is carried out in the LMIC setting). Would the call consider providing part funding for studies? RIGHT will not fund projects jointly with other funders. An application to RIGHT must be for a selfcontained study with a clearly defined end-point. Eligibility Do applications to the RIGHT call have to fulfil Official Development Assistance (ODA) eligibility? All applications to RIGHT Call 1 must fulfil ODA eligibility. The research must be focused on improving the health and welfare of the poorest and most vulnerable people in LMICs. In order to be eligible to receive ODA funding, applications must demonstrate how they meet ODA compliance criteria and outline: Which country or countries on the DAC list of ODA eligible countries will directly benefit? How the application is directly and primarily relevant to the development challenges of those countries? How the outcomes will promote the health and welfare of a country or countries on the DAC list? Can research teams that were unsuccessful in other NIHR Global Health Calls re-apply? Research Teams that have applied unsuccessfully for other NIHR Global Health Research calls can re-apply so long as they are in remit, declare this on their application, and address any concerns raised by the original panel. 8

9 What organisations are eligible to apply for funding from RIGHT? Applications can be made from UK-based Higher Education Institutions (HEIs) or research institutes. If the application is successful, the UK organisation will act as the contracting organisation, meaning that it will be the recipient of the funds, and will ultimately be responsible for the delivery of the research. The sponsor of the research, or the organisation directly responsible for securing the arrangements to initiate, manage and finance a study, can be either the contracting institution or a collaborating partner, as long as that organisation is capable of fulfilling the role of a research sponsor as set out in the Research Governance Framework for Health & Social Care. What types of organisations can be party to an application to RIGHT? The lead organisation must be a UK-based HEI or research institute. Individuals from UK based NHS organisations can be co-applicants or partners. Applications with academic partners in LMIC are particularly encouraged. Other types of organisations (e.g. charities) can be involved as long as a clear rationale is provided and their role is well justified. A commercial company could also be party to the application, but the RIGHT award would not include research costs to be paid to a commercial company if that company would obtain financial benefit from the research. RIGHT awards could include the research costs of a commercial company only if there is no financial benefit and if the company has a track record in non-commercial research. We would expect any resulting intellectual property from the research to be vested in the UK and /or LMIC academic organisation. Where this arises as a result of joint UK and LMIC activity we expect that arrangements are made to ensure equitable and fair distribution of intellectual property rights Can a HEI submit multiple applications to RIGHT Call 1? Yes. There is no limit to the number of applications that a HEI can submit to the call. What is the RIGHT policy on partnering with co-applicants or organisations within LMICs? A co-applicant or partner organisation based in LMICs is actively encouraged to ensure equitable partnerships. You may find the guidance provided by the UK Collaborative on Development Research useful. Can an organisation outside of the UK submit an application? No, the lead organisation must be a HEI or research institute based in the UK. Can organisations in LMICs be lead applicants? No, the Department of Health and Social Care can only issue contracts to UK based institutions. Can more than one organisation collaborate in a joint application to RIGHT? Joint applications are welcome but one organisation will need to take the lead role and we expect to see evidence of academic collaboration and equitable partnerships. Are there any issues in collaborating with international organisations such as World Health Organization? No, Collaborating with international organisations such as World Health Organization is allowed under the RIGHT Call. 9

10 Can an individual researcher be involved in other applications as collaborators or coapplicants if they are the leading applicant on another application? An individual can be involved in other applications providing the appropriate amount of time is dedicated to delivering the research of any funded applications. Can current NIHR GHR award holders apply to the RIGHT Call 1? Yes, however current NIHR GHR award holders would need to justify how a new research project could be effectively supported. Will the NIHR act as research sponsor for the projects that are funded via this call? No, the NIHR is a distributed organisation providing a strategic framework for the different elements of NHS and Department of Health and Social Care funded and supported research. Your proposal Are there any guidelines on how the funding should be split between the lead UK institution and any LMIC organisation? There are no set guidelines as to the percentage breakdown of funding between partnering organisation. However, your research must be ODA eligible (directly and primarily of benefit to the LMIC partner) and it should be made clear in the application how funds will flow to the LMIC. All costs must be fully justified and reflect the principles of equitable partnerships. Can the projects be based in an LMIC? Yes, if the funding is routed through a UK institution and the lead applicant is employed by that same institution. Will LMIC partners receive direct funding from NIHR or via the lead UK institution? As per the guidance, all funds will be provided to the host UK institution. The Host institution will be responsible for disbursing funds to the LMIC institution. Can funding be disbursed to LMIC institutions? Yes. We strongly encourage partnerships with LMIC researchers and institutions and would welcome this, at the discretion of the lead institution. Are there any policy restrictions on the location for the research? i.e.: are there countries that would not be allowed to receive funds/be supported. There are currently no restrictions on funding work in specific countries, other than the ODA-eligibility criterium of being on the OECD DAC-list. We would recommend, however, that research teams consider Foreign and Commonwealth Office (FCO) advice and be clear in their proposal as to how they approach risk and duty of care of everyone involved in their research. How many LMIC partners are expected? As many as required to deliver the programme of work. However, please consider in your application the non-research resources required to manage multiple LMIC partners (eg. Financial management, due diligence, programme management etc.) 10

11 Could you clarify if it is permitted to include more than one LMIC in the proposal and if this is preferred or if a single country applicant is equally acceptable? There is no limit or preference on the number of LMICs that can be included as part of the research proposal. The number included should be as required to deliver the programme of work. Please consider in your application the non-research resources required to manage multiple LMIC partners. Who should be included as co-applicants from LMIC researchers and delivery partners? NIHR considers co-applicants as those individuals with responsibility for the day to day management and delivery of the project and can include patients, carers and service users. Co-applicants are considered part of the project team and are expected to share responsibility for its successful delivery. NIHR considers collaborators as those individuals who provide a substantial intellectual contribution and/or will play a role in delivering the programme of work Can we include both academic partners and delivery partners in the LMICs? Yes, providing full justification is given for inclusion in your application. What is considered value for money? The NIHR RIGHT programme considers good value for money as the optimal use of resources to achieve the intended outcomes. Optimal being considered as the most desirable possible given expressed or implied restrictions or constraints. Value for money goes beyond achieving the lowest initial price and includes consideration of Economy, Efficiency, Effectiveness, and Equity (as appropriate) and what these mean in the context of a research proposal: Economy: Are we buying inputs of the appropriate quality at the right price? (Inputs are things such as staff, consultants, raw materials and capital that are used to produce outputs) Efficiency: How well do we convert inputs into outputs? (Outputs are results delivered by us or our agents to an external party. We exercise strong control over the quality and quantity of outputs) Effectiveness: How well are the outputs from an intervention achieving the desired outcome? (Note that in contrast to outputs, we do not exercise direct control over outcomes) Equity: the extent to which the outputs of our interventions are equitably distributed. Will projects costed under 3m/over 5m be funded? Proposals for projects costed under 3m will be considered, but projects costed above 5m will not be considered. How many projects are you expecting to fund? There is no fixed target for the number of projects we wish to fund. The 30m will be allocated according to the quality of applications received and the selection panel will take a view when making their recommendations. Can we cost for research posts in the LMIC where there is currently none? Yes, these costs can be included. 11

12 What about the cost of UK-based project managers / supervisors which will be involved in project management and project monitoring and evaluation? Are you saying these costs will be ineligible? No - these costs are eligible. We are very keen that these costs are included to ensure successful project delivery. NIHR encourages close collaboration with your LMIC partners to establish were these support positions are best located. I am planning on conducting a study / delivering an intervention in an LMIC healthcare setting. Can you explain how to categorise the costs? If you are conducting research that requires an intervention to be delivered in the LMIC you are permitted to claim for External Intervention Costs (EIC). These are the costs that are additional to routine clinical treatment in the local setting. For comparison, in the UK these would be similar to NHS support or excess treatment costs. My study involves delivery of an intervention in the UK NHS, how should this be categorised? RIGHT is not designed for funding interventions in the UK. RIGHT forms part of the UK Government s commitment to ODA and therefore must be primarily for the benefit of the LMIC population. Any proposed intervention delivered in the UK will need to be clearly justified in this context. Funding for such studies within the context of RIGHT is likely to be exceptional / unusual and would be dependent on a very clear route to community and patient benefit in the LMIC. If the research involves an intervention being delivered in the UK NHS standard AcoRD regulations in respect of NHS Support Costs and NHS Treatment costs apply. See Do I need to account for inflation when costing the application? Costs must be provided at current prices and should not include inflation. An adjustment for inflation will be made centrally by NIHR CCF annually thereafter at rates set by the Department of Health and Social Care. Whilst allowances for incremental increases should be included on the form, nationally or locally agreed pay increases should be excluded. Is it possible for directly-incurred staff to also be co-investigators? Or is it only directlyallocated staff who can be co-investigators? Directly incurred staff can be a co-applicant on the grant providing the individual fulfils the NIHR criteria of co-applicant. The NIHR considers co-applicants as those individuals with responsibility for the day to day management and delivery of the project and can include patients, carers and service users. Co-applicants are considered part of the project team and are expected to share responsibility for its successful delivery. Could you confirm whether the 5,000 equipment cost limit this is for all smaller pieces of equipment purchased, or that no single item can cost more than 5K, but multiple items can be purchased which could total over 5,000? 12

13 A single piece of equipment must not exceed 5K. Multiple equipment items can be purchased such that the total is over 5k however all pieces of equipment and the associated costs should be fully justified in the application to ensure value for money. Can more than 5,000 be used for updating existing items of equipment, rather than purchasing new items? Any maintenance and related costs regarding the equipment piece which are not already considered under estate costs will be considered in equipment costs. The cost of updating an existing piece of equipment should not exceed 5K. If the purchase price is over 5K then leasing options, should be considered. Where applicants are leasing equipment pieces of more than 5,000, a comparison of leasing versus purchasing costs must be provided in Justification of Costs section. Can larger items of equipment for more than 5,000 be purchased by including some costs within estates charges? No, for new pieces of equipment the cost of the equipment item and maintenance costs should be included under equipment costs. If the purchase price is over 5,000 then leasing options should be considered. Where applicants are leasing equipment pieces of more than 5,000, a comparison of leasing versus purchasing costs must be provided in Justification of Costs section. What value should be added to the Stage 1 Financial Summary Form for a UK based Higher Education Institution, 100% FEC or the amount being requested from NIHR, i.e. 80% FEC? For STAGE 1 of the RIGHT Call - the UK HEI costs that should be added to the STAGE 1 financial summary form is the 80% FEC value that is being requested from NIHR. What is considered to be appropriate community and public involvement in a RIGHT application? In order to ensure that the research is appropriate as well as scientifically and ethically sound, relevant community groups and organisations from LMICs must be involved in a meaningful process that will help guide the research from its design to the dissemination of results. There is no standard model for appropriate community and public involvement as RIGHT applications vary immensely. Information and resources to assist you can be found on the INVOLVE website (a detailed definition of public involvement in research, briefing notes for researchers on how to involve patients and the public and an involvement cost calculator and budgeting guide). You may also find it helpful to refer to Mesh ( a collaborative open-access web space that provides resources, encourages networking and shares good practice to bridge the gap between the research community and the general public in low and middle income countries. Applicants successful at Stage 1 will be invited to participate in a webinar on community and public involvement. When is the deadline for submitting questions on the call remit or process? 13

14 23 July